Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 183483-29-6 | MDL No. : | MFCD07367935 |
Formula : | C7H6BrNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SJFRXYCVLZOAEU-UHFFFAOYSA-N |
M.W : | 216.03 | Pubchem ID : | 29921601 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.14 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.48 |
TPSA : | 50.19 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.67 cm/s |
Log Po/w (iLOGP) : | 1.32 |
Log Po/w (XLOGP3) : | 1.34 |
Log Po/w (WLOGP) : | 1.47 |
Log Po/w (MLOGP) : | 0.82 |
Log Po/w (SILICOS-IT) : | 1.72 |
Consensus Log Po/w : | 1.34 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.3 |
Solubility : | 1.09 mg/ml ; 0.00507 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.0 |
Solubility : | 2.18 mg/ml ; 0.0101 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.66 |
Solubility : | 0.469 mg/ml ; 0.00217 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.82 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
90% | With water; lithium hydroxide In tetrahydrofuran; methanol at 20℃; for 0.166667 h; | To a solution of ethyl 2-(2-bromo-4-pyridyl)acetate (1.00 g, 4.10 mmol) in a mixture of THF (5 mL), MeOH (10 mL) and water (5 mL) was added lithium hydroxide (294 mg, 12.3 mmol) and the reaction mixture was stirred at 20 °C for 10 mins. On completion, the reaction mixture was concentrated in vacuo to remove THF and MeOH and diluted with 10 mL water. The aqueous phase was acidified with 2N HCl solution until pH = 2. The mixture was filtered and the filter cake was dried in vacuo to give the title compound (850 mg, 90percent yield) as a white solid. LCMS: (ES+) m/z (M+H)+= 217.9, tR = 0.539. |
[ 926294-07-7 ]
6-Bromo-4-methylnicotinaldehyde
Similarity: 0.79
[ 864674-02-2 ]
1-(2-Bromopyridin-4-yl)ethanone
Similarity: 0.76
[ 118289-17-1 ]
2-Bromopyridine-4-carboxaldehyde
Similarity: 0.75
[ 6622-91-9 ]
2-(Pyridin-4-yl)acetic acid hydrochloride
Similarity: 0.81
[ 502509-10-6 ]
4-(2-Hydroxyethyl)picolinic acid
Similarity: 0.75
[ 502509-05-9 ]
2-(2-Cyanopyridin-4-yl)acetic acid
Similarity: 0.74
[ 920297-29-6 ]
1-(Pyridin-4-yl)cyclopropanecarboxylic acid
Similarity: 0.73
[ 6622-91-9 ]
2-(Pyridin-4-yl)acetic acid hydrochloride
Similarity: 0.81
[ 926294-07-7 ]
6-Bromo-4-methylnicotinaldehyde
Similarity: 0.79
[ 864674-02-2 ]
1-(2-Bromopyridin-4-yl)ethanone
Similarity: 0.76
[ 29800-89-3 ]
Methyl 2-(pyridin-4-yl)acetate
Similarity: 0.76
[ 502509-10-6 ]
4-(2-Hydroxyethyl)picolinic acid
Similarity: 0.75